Latest news
Phase 3 Dermatomyositis Trial Sees Brepocitinib Meet Primary Endpoint - HCPLiveHCPLive · Sun, 09 Aug 2026 14:10:50 GMTSocrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study - HCPLiveHCPLive · Fri, 07 Aug 2026 23:10:36 GMTNamilumab Fails to Meet Primary End Point in Pulmonary Sarcoidosis - HCPLiveHCPLive · Fri, 07 Aug 2026 14:06:13 GMT